Andreas Mueller

Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial

Marco Colleoni, Weixiu Luo, Per Karlsson et al. · The Lancet Oncology · 2017 · 120 citations

Breast Oncology, Medicine, Cancer Management +7

Fulvestrant with or without selumetinib, a MEK 1/2 inhibitor, in breast cancer progressing after aromatase inhibitor therapy: A multicentre randomised placebo-controlled double-blind phase II trial, SAKK 21/08

Khalil Zaman, Christoph Mamot, Ursula Hasler-Strub et al. · European Journal of Cancer · 2015 · 50 citations

Breast Cancer Progressing, Breast Oncology, Oncology +11

Intravitreal toxicology and duration of efficacy of a novel antiviral lipid prodrug of ganciclovir in liposome formulation.

Lingyun Cheng, Karl Y. Hostetler, Sunan Chaidhawangul et al. · PubMed · 2000 · 49 citations

The effects of an integrated supportive care intervention on quality of life outcomes in outpatients with breast and gynecologic cancer undergoing chemotherapy: Results from a randomized controlled trial

Nadja Klafke, Cornelia Mahler, Cornelia von Hagens et al. · Cancer Medicine · 2019 · 34 citations · Full text

Comparison of a new image-guided system versus partial coherence interferometry, Scheimpflug imaging, and optical low-coherence reflectometry devices: Keratometry and repeatability

Andreas Mueller, Bettina Thomas, Gerd U. Auffarth et al. · Journal of Cataract & Refractive Surgery · 2016 · 27 citations